PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1559694
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1559694
Benign Prostatic Hyperplasia Devices
Global Benign Prostatic Hyperplasia Devices Market to Reach US$816.5 Million by 2030
The global market for Benign Prostatic Hyperplasia Devices estimated at US$582.8 Million in the year 2023, is expected to reach US$816.5 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$496.9 Million by the end of the analysis period. Growth in the Urology Clinics End-Use segment is estimated at 4.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$158.5 Million While China is Forecast to Grow at 4.7% CAGR
The Benign Prostatic Hyperplasia Devices market in the U.S. is estimated at US$158.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$129.5 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
Global Benign Prostatic Hyperplasia Devices Market - Key Trends and Drivers Summarized
What Role Do Benign Prostatic Hyperplasia Devices Play in Modern Treatment?
Benign Prostatic Hyperplasia (BPH) devices are essential tools in the management of prostate enlargement, offering minimally invasive solutions that significantly reduce the symptoms and complications associated with this common condition in aging men. These devices provide alternatives to traditional surgical approaches, enabling more targeted and patient-friendly treatments. BPH devices include a range of technologies such as transurethral resection of the prostate (TURP) instruments, laser therapy systems, prostatic stents, and newer treatments like water vapor therapy and prostatic urethral lift (PUL) systems. By either removing or repositioning excess prostate tissue that blocks the urethra, these devices improve urinary flow and alleviate related symptoms like frequent urination and urinary retention. The introduction of these advanced devices has expanded the options available to men, allowing for more personalized treatment strategies that align with their specific health needs and recovery goals.
How Are Technological Innovations Enhancing BPH Device Effectiveness?
Technological innovations have significantly enhanced the effectiveness and safety of BPH devices, leading to better patient outcomes and broader treatment options. Laser therapy systems, such as holmium laser enucleation of the prostate (HoLEP), leverage precision laser technology to remove excess tissue with minimal invasiveness, reducing the risks associated with traditional surgical methods. Innovations like water vapor therapy, which utilizes steam to shrink prostate tissue, offer a non-invasive alternative with excellent long-term results. Additionally, the development of prostatic urethral lift (PUL) systems has revolutionized BPH treatment by providing a method to physically reposition the prostate tissue without cutting or removing it, thus preserving sexual function and ensuring quicker recovery. These advancements are not only improving the success rates of BPH treatments but also making them more accessible and less disruptive to patients' lives, encouraging more men to seek out these innovative solutions.
Why Is There Increasing Demand for BPH Devices Across Healthcare Systems?
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Global Economic Update
- Benign Prostatic Hyperplasia Devices - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
III. MARKET ANALYSIS
IV. COMPETITION
